Inhibidores de ALK: progresos terapéuticos - page 30

Role for multiple sequential ALK inhibitors
Secondary ALK mutation
Fribroulet, et al. Cancer Discov 2012; Katayama, et al. Clin Cancer Res 2014; Ou, et al. J Thorac Oncol 2014
Ou, et al. Lung Cancer 2016; Gainor, et al. Cancer Discov 2016
F1174V
F1174V
Ceritinib
PD
Crizotinib
Alectinib
Therapy
Crizotinib
PD
Alectinib
2
L
1L
Ceritinib
3L
PD
I1171T
Therapy
INDICACIÓN NO APROBADA, EN INVESTIGACIÓN
1...,20,21,22,23,24,25,26,27,28,29 31,32,33,34,35,36,37,38,39,40,...48
Powered by FlippingBook